このアイテムのアクセス数: 244

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
44_397.pdf4.12 MBAdobe PDF見る/開く
完全メタデータレコード
DCフィールド言語
dc.contributor.authorKUO, junne-Yihen
dc.contributor.authorOHMOTO, Yasukazuen
dc.contributor.authorYOSHIDA, Osamuen
dc.contributor.alternative郭, 俊逸ja
dc.contributor.alternative大本, 安一ja
dc.contributor.alternative吉田, 修ja
dc.date.accessioned2010-05-28T06:19:39Z-
dc.date.available2010-05-28T06:19:39Z-
dc.date.issued1998-06-
dc.identifier.issn0018-1994-
dc.identifier.urihttp://hdl.handle.net/2433/116199-
dc.description.abstract対象は60例の泌尿器科癌患者.その内訳は膀胱癌30例, 腎癌12例, 前立腺癌18例であった.また, 対照群は健常者16例.測定方法はヘパリン採血した全血0.1mlずつを, 6段階(0, 0.1, 0.3, 1, 3, 5μg/ml)の濃度のリポポリサッカライド添加無血清培地にて24時間培養し, その上清をIL-1α, IL-1βに対するモノクローナル抗体を用いたELISA法にて測定した.リポポリサッカライドを含まない条件での全血1mlあたりのIL-1α, IL-1β産生量は, 膀胱癌患者, 腎癌患者, 前立腺癌患者では健常者と比較して有意差を認めなかった.次に5段階濃度のリポポリサッカライドを用いた場合, 膀胱癌患者, 腎癌患者, 前立腺癌患者, 健常者におけるIL-1α, IL-1β産生量はdose responseを示した.また, IL-1βの産生量はIL-1αより高値であった.しかし, 膀胱癌患者, 腎癌患者, 前立腺癌患者と対照群の間でのIL-1α, IL-1β産生量は有意差を認めなかったja
dc.description.abstractThe activities of interleukin-1 alpha (IL-1 alpha) and interleukin-1 beta) were investigated in peripheral whole blood from 30 patients with bladder cancer, 12 patients with renal cell carcinoma, 18 patients with prostatic cancer and 16 healthy subjects. Heparinized blood was cultured in the absence and presence of various concentrations of bacterial lipopolysaccharide (LPS). The culture supernatants were obtained and activities of IL-1 alpha and IL-1 beta were determined by enzyme-linked immunosorbent assay (ELISA). In the absence of LPS stimulation, neither IL-1 alpha nor IL-1 beta was spontaneously produced in blood cultures from patients with bladder cancer, renal cell carcinoma or prostatic cancer compared with control subjects. After stimulation with various concentrations of LPS, blood cultures from patients with bladder cancer, renal cell carcinoma, prostatic cancer, those from control subjects produced IL-1 alpha and IL-1 beta in a dose-dependent manner, and IL-1 beta was predominant in all supernatants. The activities of IL-1 alpha and IL-1 beta showed no significant differences between the patients with bladder cancer, renal cell carcinoma or prostatic cancer and control subjects. This study suggested that the patients with bladder cancer renal cell carcinoma and prostatic cancer did not spontaneously produce IL-1 alpha or IL-1 beta, but that the ability to produce IL-1 alpha and IL-1 beta in response to LPS stimulation was not significantly impaired.en
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisher泌尿器科紀要刊行会ja
dc.subjectUrological canceren
dc.subjectIL-la and IL-1g productionen
dc.subjectPeripheral whole blooden
dc.subjectEnzyme-linkeden
dc.subject.ndc494.9-
dc.titleInterleukin-1 alpha and interleukin-1 beta production in peripheral whole blood from patients with urological canceren
dc.title.alternative泌尿器科癌患者末梢血におけるInterleukin-1α, Interleukin-1β産生能の検討ja
dc.typedepartmental bulletin paper-
dc.type.niitypeDepartmental Bulletin Paper-
dc.identifier.ncidAN00208315-
dc.identifier.jtitle泌尿器科紀要ja
dc.identifier.volume44-
dc.identifier.issue6-
dc.identifier.spage397-
dc.identifier.epage402-
dc.textversionpublisher-
dc.sortkey05-
dc.addressthe Department of Urology, National Yang- Ming Universityand Division of Urology, Department of Surgery, Veterans General Hospital- Taipei, Taiwan, Republic of Chinaen
dc.addressthe Laboratories of Cellular Technology, Otsuka Pharmaceutical Co. Ltd., Tokushimaen
dc.addressthe Department of Urology, Faculty of Medicine, Kyoto University, Kyotoen
dc.address.alternative国立陽明大学医学院泌尿学科, 台北榮民総医院外科部泌尿外科ja
dc.address.alternative大塚製薬株式会社細胞工学研究所ja
dc.address.alternative京都大学医学部泌尿器科学教室ja
dc.identifier.pmid9719938-
dcterms.accessRightsopen access-
dc.identifier.pissn0018-1994-
dc.identifier.jtitle-alternativeActa urologica Japonicala
dc.identifier.jtitle-alternativeHinyokika Kiyoen
出現コレクション:Vol.44 No.6

アイテムの簡略レコードを表示する

Export to RefWorks


出力フォーマット 


このリポジトリに保管されているアイテムはすべて著作権により保護されています。